Covista (CVSA) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jan, 2026Executive summary
Revenue grew 13.9% year-over-year to $447.7 million in Q2 2025, with total enrollment up 11.6% to 91,264 students, marking the sixth consecutive quarter of growth, driven by Chamberlain and Walden universities.
Adjusted EBITDA increased 35.1% to $125.0 million, with margin expanding by 440 basis points to 27.9%.
Adjusted EPS rose 47.2% to $1.81, while diluted EPS reached $1.98, reflecting higher revenue and lower share count.
The company raised fiscal 2025 guidance, expecting revenue of $1.73B–$1.76B and adjusted EPS of $6.10–$6.30.
Operational excellence, digital transformation, and the "Growth with Purpose" strategy are driving record enrollments and margin expansion.
Financial highlights
Q2 revenue was $447.7 million, up 13.9% year-over-year, with growth across all segments.
Adjusted EBITDA was $125.0 million, up 35.1% year-over-year, with a margin of 27.9%.
Adjusted operating income rose 34.2% to $101.4 million; adjusted net income was $69.4 million, up 38.1%.
Free cash flow (TTM) was $232 million; cash and equivalents were $194 million as of Dec. 31, 2024.
471,327 shares repurchased in Q2, with $140 million remaining on the share repurchase authorization.
Outlook and guidance
Fiscal 2025 revenue guidance raised to $1.73B–$1.76B, representing 9–11% year-over-year growth.
Adjusted EPS guidance increased to $6.10–$6.30, up 21.5–25.5% year-over-year.
Expecting over 100 basis points of adjusted EBITDA margin expansion in fiscal 2025.
Revenue growth anticipated to be higher in 1H 2025 than 2H 2025.
Adjusted effective tax rate anticipated at approximately 23% for the year.
Latest events from Covista
- AI-driven growth and operational excellence target 120,000+ students and double-digit EPS by FY29.CVSA
Investor Day 202625 Feb 2026 - Raised EPS guidance, strong enrollment, and $750M buyback drive robust financial results.CVSA
Q2 20263 Feb 2026 - Double-digit enrollment and earnings growth in FY24, with robust FY25 outlook.CVSA
Q4 20242 Feb 2026 - Record enrollment and margin gains highlight leadership in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Double-digit revenue and enrollment growth led to higher earnings and raised FY25 guidance.CVSA
Q1 202518 Jan 2026 - Record financial and academic results, with strong governance and pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - FY2024 saw record growth, strong diversity, and robust pay-for-performance alignment.CVSA
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and hold say-on-pay vote in November 2025.CVSA
Proxy Filing1 Dec 2025 - Record FY25 growth and strong FY26 outlook, driven by enrollment and partnerships.CVSA
Q4 202523 Nov 2025